{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:12:44Z","timestamp":1789776764097,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A high incidence of upper urinary tract urothelial carcinoma has been reported in the southwestern area of Taiwan, where arsenic water contamination was considered the main cause. However, there is no definite proof to show a correlation between arsenic water contamination and upper urinary tract urothelial carcinoma. To investigate the clinical and epidemiological features of patients with upper urinary tract urothelial carcinoma between arsenic water endemic and non-endemic areas, we analyzed patients in terms of characteristics, stratified overall survival, disease-free survival, and cancer-specific survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The records of a total of 1194 patients diagnosed with upper urinary tract urothelial carcinoma were retrospectively reviewed. Clinical data and current medical status were collected from the medical records. Statistical analyses were performed to determine the clinical variables and stratified survival curves between endemic and non-endemic groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Female predominance was revealed in both endemic and non-endemic groups (male:female ratio\u2009=\u20091:1.2\u20131.4). No statistical differences were found in histological types, staging, and tumor size between the two groups. Nonetheless, patients with characteristics of aging and having end-stage renal disease were outnumbered in the non-endemic group, while a higher prevalence of previous bladder tumors and more ureteral tumors were found in the endemic group. Adjusted stratified cumulative survival curves suggested a poorer prognosis in endemic patients, especially in disease-free survival of early stage disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A higher mortality rate with more previous bladder cancer history and ureteral tumors was seen in patients with upper urinary tract urothelial carcinoma residing in the arsenic water contamination area. This may be attributed to the long-term carcinogenic effect of arsenic underground water.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-07799-4","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T15:03:14Z","timestamp":1611068594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area"],"prefix":"10.1186","volume":"21","author":[{"given":"Che-Wei","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Wen","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-You","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pai-Yu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Tai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu-Che","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2405-4874","authenticated-orcid":false,"given":"Hsiang-Ying","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"issue":"1","key":"7799_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","volume":"73","author":"M Roupret","year":"2018","unstructured":"Roupret M, et al. European association of urology guidelines on upper urinary tract Urothelial carcinoma: 2017 update. Eur Urol. 2018;73(1):111\u201322.","journal-title":"Eur Urol"},{"issue":"5","key":"7799_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/0090-4295(82)90601-X","volume":"19","author":"BN Nocks","year":"1982","unstructured":"Nocks BN, et al. Transitional cell carcinoma of renal pelvis. Urology. 1982;19(5):472\u20137.","journal-title":"Urology"},{"issue":"5","key":"7799_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0090-4295(02)01529-7","volume":"59","author":"MH Yang","year":"2002","unstructured":"Yang MH, et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology. 2002;59(5):681\u20137.","journal-title":"Urology"},{"issue":"3","key":"7799_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/bjc.1986.65","volume":"53","author":"CJ Chen","year":"1986","unstructured":"Chen CJ, et al. A retrospective study on malignant neoplasms of bladder, lung and liver in Blackfoot disease endemic area in Taiwan. Br J Cancer. 1986;53(3):399\u2013405.","journal-title":"Br J Cancer"},{"issue":"4","key":"7799_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/ije\/27.4.561","volume":"27","author":"C Hopenhayn-Rich","year":"1998","unstructured":"Hopenhayn-Rich C, Biggs ML, Smith AH. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol. 1998;27(4):561\u20139.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"7799_CR6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1289\/ehp.99107705","volume":"107","author":"P Kurttio","year":"1999","unstructured":"Kurttio P, et al. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect. 1999;107(9):705\u201310.","journal-title":"Environ Health Perspect"},{"issue":"3","key":"7799_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/jnci\/djx201","volume":"110","author":"AH Smith","year":"2018","unstructured":"Smith AH, et al. Lung, bladder, and kidney Cancer mortality 40 years after arsenic exposure reduction. J Natl Cancer Inst. 2018;110(3):241\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"11 Pt 2","key":"7799_CR8","first-page":"5895","volume":"45","author":"CJ Chen","year":"1985","unstructured":"Chen CJ, et al. Malignant neoplasms among residents of a Blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985;45(11 Pt 2):5895\u20139.","journal-title":"Cancer Res"},{"issue":"5","key":"7799_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/aje\/153.5.411","volume":"153","author":"HY Chiou","year":"2001","unstructured":"Chiou HY, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol. 2001;153(5):411\u20138.","journal-title":"Am J Epidemiol"},{"key":"7799_CR10","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jhazmat.2012.08.056","volume":"262","author":"YH Wang","year":"2013","unstructured":"Wang YH, et al. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer. J Hazard Mater. 2013;262:1139\u201346.","journal-title":"J Hazard Mater"},{"issue":"1","key":"7799_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1464-410X.2008.07565.x","volume":"102","author":"LB Tan","year":"2008","unstructured":"Tan LB, Chen KT, Guo HR. Clinical and epidemiological features of patients with genitourinary tract tumour in a Blackfoot disease endemic area of Taiwan. BJU Int. 2008;102(1):48\u201354.","journal-title":"BJU Int"},{"key":"7799_CR12","unstructured":"Mostofi FK, S.L., Torloni H., Histologic typing of urinary bladders. In Mostofi FK ed. International histological classification of tumors. . Geneva: WHO, 1973: p. 21\u201331."},{"key":"7799_CR13","unstructured":"In: Eble JN, S.G., Epstein JL, et al, eds, World Health Organization Classification of tumors. Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs. Lyon. 2004: Lyon, France: IARCC Publishing;."},{"key":"7799_CR14","unstructured":"Cancer., A.J.C.o., AJCC Cancer Staging Handbook, 5th ed. Philadelphia: Lippincott-Raven Publishers, 1998."},{"issue":"2","key":"7799_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.juro.2008.10.003","volume":"181","author":"CH Chen","year":"2009","unstructured":"Chen CH, et al. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in Taiwan. J Urol. 2009;181(2):547\u201352 discussion 553.","journal-title":"J Urol"},{"issue":"5","key":"7799_CR16","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","volume":"164","author":"JJ Munoz","year":"2000","unstructured":"Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol. 2000;164(5):1523\u20135.","journal-title":"J Urol"},{"issue":"5","key":"7799_CR17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0959-8049(99)00012-X","volume":"35","author":"M Ozsahin","year":"1999","unstructured":"Ozsahin M, et al. Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre rare Cancer network study. Eur J Cancer. 1999;35(5):738\u201343.","journal-title":"Eur J Cancer"},{"issue":"7","key":"7799_CR18","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","volume":"107","author":"JD Raman","year":"2011","unstructured":"Raman JD, et al. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. BJU Int. 2011;107(7):1059\u201364.","journal-title":"BJU Int"},{"issue":"6","key":"7799_CR19","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1342::AID-CNCR17>3.0.CO;2-B","volume":"85","author":"YH Chou","year":"1999","unstructured":"Chou YH, Huang CH. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer. 1999;85(6):1342\u20134.","journal-title":"Cancer"},{"issue":"4","key":"7799_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","volume":"58","author":"RL Favaretto","year":"2010","unstructured":"Favaretto RL, et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol. 2010;58(4):574\u201380.","journal-title":"Eur Urol"},{"issue":"4","key":"7799_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00345-010-0594-7","volume":"29","author":"SF Shariat","year":"2011","unstructured":"Shariat SF, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011;29(4):481\u20136.","journal-title":"World J Urol"},{"issue":"15","key":"7799_CR22","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.purol.2014.06.012","volume":"24","author":"A Ouzzane","year":"2014","unstructured":"Ouzzane A, et al. Epidemiology and risk factors of upper urinary tract tumors: literature review for the yearly scientific report of the French National Association of urology. Prog Urol. 2014;24(15):966\u201376.","journal-title":"Prog Urol"},{"issue":"Suppl 1","key":"7799_CR23","doi-asserted-by":"publisher","first-page":"i51","DOI":"10.1136\/tc.2004.008011","volume":"14","author":"CP Wen","year":"2005","unstructured":"Wen CP, et al. Smoking behaviour in Taiwan, 2001. Tob Control. 2005;14(Suppl 1):i51\u20135.","journal-title":"Tob Control"},{"key":"7799_CR24","first-page":"149750","volume":"2014","author":"SM Wang","year":"2014","unstructured":"Wang SM, et al. Increased upper and lower tract urothelial carcinoma in patients with end-stage renal disease: a nationwide cohort study in Taiwan during 1997-2008. Biomed Res Int. 2014;2014:149750.","journal-title":"Biomed Res Int"},{"issue":"5","key":"7799_CR25","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.eururo.2008.01.054","volume":"54","author":"CC Li","year":"2008","unstructured":"Li CC, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol. 2008;54(5):1127\u201334.","journal-title":"Eur Urol"},{"issue":"7","key":"7799_CR26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1289\/ehp.8704","volume":"114","author":"SH Lamm","year":"2006","unstructured":"Lamm SH, et al. Arsenic cancer risk confounder in Southwest Taiwan data set. Environ Health Perspect. 2006;114(7):1077\u201382.","journal-title":"Environ Health Perspect"},{"issue":"3","key":"7799_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.taap.2003.10.011","volume":"198","author":"A Schoen","year":"2004","unstructured":"Schoen A, et al. Arsenic toxicity at low doses: epidemiological and mode of action considerations. Toxicol Appl Pharmacol. 2004;198(3):253\u201367.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"7799_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/taap.1999.8872","volume":"163","author":"JS Petrick","year":"2000","unstructured":"Petrick JS, et al. Monomethylarsonous acid (MMA (III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol. 2000;163(2):203\u20137.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"7799_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.taap.2006.10.010","volume":"222","author":"SM Cohen","year":"2007","unstructured":"Cohen SM, et al. Arsenic-induced bladder cancer in an animal model. Toxicol Appl Pharmacol. 2007;222(3):258\u201363 s.","journal-title":"Toxicol Appl Pharmacol"},{"key":"7799_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.toxrep.2014.07.004","volume":"1","author":"M Medeiros","year":"2014","unstructured":"Medeiros M, et al. Expression of selected pathway-marker genes in human Urothelial cells exposed chronically to a non-cytotoxic concentration of Monomethylarsonous acid. Toxicol Rep. 2014;1:421\u201334.","journal-title":"Toxicol Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07799-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-021-07799-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07799-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T15:04:56Z","timestamp":1611068696000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-07799-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7799"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-07799-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-56327\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. The requirement for consent and guidelines was waived by institutional review boards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed for the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}